next generation EBV TK gene expression stimulators (Phoenicia Biosciences)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namenext generation EBV TK gene expression stimulators (Phoenicia Biosciences)

Drug Alias Namenucleoside short-chain fatty acid derivatives (Phoenicia Biosciences)next generation EBV thymidine kinase gene expression stimulator (Phoenicia Biosciences)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionThymidine kinase stimulants

TargetsThymidine kinase

Therapy Area/IndicationsLymphoproliferative DisordersNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPhoenicia Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesPhoenicia Biosciences Inc

Inactive CompaniesN/A

Active IndicationsLymphoproliferative DisordersNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A